# To Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken Together

> **NCT01478568** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 28 (actual)

## Conditions studied

- Pharmacokinetics of Mirabegron
- Healthy Subjects

## Interventions

- **DRUG:** mirabegron
- **DRUG:** desipramine

## Key facts

- **NCT ID:** NCT01478568
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2014-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01478568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01478568, "To Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken Together". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01478568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*